In this Clinical Trials in Genitourinary Cancers series podcast, experts discuss 3 clinical trials aiming to identify new treatments for prostate, bladder, and kidney cancers.
Clinical Trials in Genitourinary Cancers: Investigating New Treatments for Kidney, Bladder, and Prostate Cancers
In the first podcast of the Clinical Trials in Genitourinary Cancers series, experts discuss 3 clinical trials that are currently exploring new ways of treating kidney, bladder, and prostate cancers.
Prostate cancer survivor Bin McLaurin was devastated by his cancer diagnosis. But then, his experience gave him new purpose in life.
The "Your Stories" podcast series from Conquer Cancer, the ASCO Foundation, provides insight into what it’s like to conquer cancer from different viewpoints. The podcasts featured here touch on how families cope with a cancer diagnosis.
ASCO Annual Meeting 2019: Treatment Advances for Metastatic Prostate Cancer and Pancreatic Cancer, Multiple Myeloma Survival Factors, and Effects of the Affordable Care Act on Cancer Care
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care.
Treating Advanced Prostate Cancer and Kidney Cancer: Research from the 2019 Genitourinary Cancers Symposium
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer.
Exercise can greatly improve the physical and mental health of men with prostate cancer. Exercise specialist Carol Michaels shares what the benefits are and how to start a program that’s right for you.
ASCO Annual Meeting 2018: Geriatric Assessment Improves Communication, Racial and Gender Differences in Cancer Treatment, and a Comparison of Cancer Treatment Costs
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include the effects of geriatric assessment on patient-doctor communication, treatments for advanced prostate cancer that may work better in black men, the possibility that women are undertreated for head and neck cancer, and a comparison of treatment costs for colorectal cancer between the U.S. and Canada.
The 2018 Genitourinary Cancers Symposium includes exciting research that focuses on effective treatment options for kidney cancer, prostate cancer, and bladder cancer.